BMI
Low glycemic index treatment (LGIT) → BMI
Low glycemic index treatment (LGIT) → BMI
Evidence profile
Key finding
HbA1c decreased from 8.33% to 7.82% (p = 0.001)
This study evaluated the effectiveness of an online low glycemic index diet for managing type 2 diabetes, showing significant improvements in several health markers.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Online low glycaemic index dietary and lifestyle recommendations
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Primary outcome
Glycated hemoglobin (HbA1c)
Comparator
Standard care and basic diabetes education
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
This study evaluated the effectiveness of an online low glycemic index diet for managing type 2 diabetes, showing significant improvements in several health markers.
These findings highlight the potential of online dietary interventions in managing type 2 diabetes, offering a practical and accessible approach for patients to improve their health outcomes. The significant reductions in HbA1c and BMI are particularly important as they are associated with lower risks of diabetes complications.
Limited generalizability due to specific participant characteristics Potential self-reporting bias in dietary adherence Short duration of the intervention may affect long-term applicability
Published in
Publication details and source links for this paper.
Jinhua C, Lixia L, Xinyi Z, et al. Effectiveness of an Online Low Glycemic Index Diet and Lifestyle Intervention for Type 2 Diabetes Management: A Randomized Controlled Trial. Archives of Public Health. 2025;83:61. doi:10.1186/s13690-025-01552-0
Save this study and add notes to your research library.
HbA1c decreased from 8.33% to 7.82% (p = 0.001)
BMI decreased from 25.73 kg/m² to 24.35 kg/m² (p < 0.001)
LDL-C decreased from 2.83 mmol/L to 2.38 mmol/L (p < 0.001)
HDL-C increased from 1.21 mmol/L to 1.35 mmol/L (p = 0.001)
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Low glycemic index treatment (LGIT) and BMI, HDL cholesterol, HbA1c, and 2 more.
This study contributes evidence to
Primary intervention
Low glycemic index treatment (LGIT)
Primary outcomes
Evidence topics
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
3
Related topics
5
Evidence pairs
461
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Low glycemic index treatment (LGIT) → BMI
Low glycemic index treatment (LGIT) → BMI
Evidence profile
Low glycemic index treatment (LGIT) → HbA1c
Low glycemic index treatment (LGIT) → HbA1c
Evidence profile
Low glycemic index treatment (LGIT) → HDL cholesterol
Low glycemic index treatment (LGIT) → HDL cholesterol
Evidence profile
Low glycemic index treatment (LGIT) → LDL cholesterol
Low glycemic index treatment (LGIT) → LDL cholesterol
Evidence profile
Low glycemic index treatment (LGIT) → Quality of life
Low glycemic index treatment (LGIT) → Quality of life
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Low glycemic index treatment (LGIT) and Body Mass Index, Low glycemic index treatment (LGIT) and HbA1c.
This study contributes to the evidence on the following intervention-outcome relationships.
Diet and Nutrition
Curated evidence collections and hubs this study is part of.
All studies measuring Adipokine and Angiogenic Markers
Measures Adipokine and Angiogenic Markers as a key outcome.
All studies measuring Body Mass Index
Measures Body Mass Index as a key outcome.
All studies measuring HbA1c
Measures HbA1c as a key outcome.
All studies on Low glycemic index treatment (LGIT)
Contributes to Low glycemic index treatment (LGIT) evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in the evidence archive.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Low glycemic index treatment (LGIT) appears to improve BMI.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
BMI
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Low glycemic index treatment (LGIT) appears to improve HDL cholesterol.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HDL cholesterol
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Low glycemic index treatment (LGIT) appears to improve HbA1c.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Low glycemic index treatment (LGIT) appears to improve LDL cholesterol.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
LDL cholesterol
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Follow the topics this study contributes to.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.